CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

Clinical trials for CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA trials appear

Sign up with your email to follow new studies for CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New trial tests which drug combo works better for young adults with leukemia

Disease control Not yet recruiting

This study aims to find out if adding a newer drug called venetoclax to standard chemotherapy works as well as or better than adding an older targeted drug called gemtuzumab ozogamicin for treating a specific type of acute myeloid leukemia (AML). It will enroll 162 younger adults…

Matched conditions: CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

Get alerted when new CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA trials appear

New trial tests which drug combo works better for young adults with leukemia